Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis.

MLA

Dong, Huijing, et al. “Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis.” Journal of Oncology, vol. 2023, Jan. 2023, p. 2525903. EBSCOhost, https://doi.org/10.1155/2023/2525903.

APA

Dong, H., Xue, C., Zheng, Y., Zhang, X., Hu, Z., Lu, X., Yu, Y., Li, J., Tan, K., & Cui, H. (2023). Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis. Journal of Oncology, 2023, 2525903. https://doi.org/10.1155/2023/2525903

Chicago

Dong, Huijing, Chongxiang Xue, Yumin Zheng, Xu Zhang, Zixin Hu, Xingyu Lu, Yixuan Yu, Jia Li, Kexin Tan, and Huijuan Cui. 2023. “Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis.” Journal of Oncology 2023 (January): 2525903. doi:10.1155/2023/2525903.